Advertisement
Advertisement

SNOA

SNOA logo

Sonoma Pharmaceuticals, Inc. Common Stock

1.15
USD
Sponsored
+0.01
+0.88%
Jun 24, 14:20 UTC -4
Closed
exchange

Pre-Market

1.13

-0.02
-2.17%

SNOA Earnings Reports

Positive Surprise Ratio

SNOA beat 11 of 21 last estimates.

52%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q1 27 (Revenue/ EPS)
$5.09M
/
-$0.30
Implied change from Q4 26 (Revenue/ EPS)
--
/
--
Implied change from Q1 26 (Revenue/ EPS)
+26.82%
/
-60.53%

Sonoma Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Jun 15, 2026, SNOA reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.20 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 4.68 million, with a --% difference. The market reacted with a -0.90% price change (close before vs. close after earnings).
Looking ahead to Q1 27, 3 analysts forecast an EPS of -0.30 USD, with revenue projected to reach 5.09 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q4 2026, Sonoma Pharmaceuticals, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved down -0.9%, changed from $1.11 before the earnings release to $1.10 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 3 analysts, Sonoma Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.30 and revenue of $5.09M for Q1 2027.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement